Tesla
TSLA
Apple
AAPL
Meta Platforms
META
Microsoft
MSFT
Petroleo Brasileiro SA Petrobras
PBR
US Stock MarketDetailed Quotes
TGTX TG Therapeutics
- 42.990
- +1.100+2.63%
Close Mar 21 16:00 ET
- 43.170
- +0.180+0.42%
Pre 04:12 ET
6.75BMarket Cap286.60P/E (TTM)
43.150High41.190Low4.65MVolume41.620Open41.890Pre Close198.72MTurnover3.18%Turnover Ratio286.60P/E (Static)157.07MShares43.15052wk High30.36P/B6.29BFloat Cap12.93052wk Low--Dividend TTM146.38MShs Float149414.006Historical High--Div YieldTTM4.68%Amplitude0.956Historical Low42.723Avg Price1Lot Size
TG Therapeutics News
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HUME DANIEL
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charney Laurence N
TG Therapeutics | 10-K: FY2024 Annual Report
TG Therapeutics | 8-K: TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WEISS MICHAEL S
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Power Sean A
TG Therapeutics | 8-K: Current report
TG Therapeutics | SCHEDULE 13G/A: Others
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Power Sean A
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
TG Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Darwin Global Management, Ltd.(0%),Dr. Abhishek Trehan(0%), etc.
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lonial Sagar
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charney Laurence N
TG Therapeutics | 144/A: Others
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Echelard Yann
TG Therapeutics | 10-Q: Q3 2024 Earnings Report
TG Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.